Curcumin Suppresses Metastasis via Sp-1, FAK Inhibition, and E-Cadherin Upregulation in Colorectal Cancer
Open Access
- 1 January 2013
- journal article
- research article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2013, 1-17
Abstract
Colorectal cancer (CRC) is a serious public health problem that results due to changes of diet and various environmental stress factors in the world. Curcumin is a traditional medicine used for treatment of a wide variety of tumors. However, antimetastasis mechanism of curcumin on CRC has not yet been completely investigated. Here, we explored the underlying molecular mechanisms of curcumin on metastasis of CRC cellsin vitroandin vivo. Curcumin significantly inhibits cell migration, invasion, and colony formationin vitroand reduces tumor growth and liver metastasisin vivo. We found that curcumin suppresses Sp-1 transcriptional activity and Sp-1 regulated genes including ADEM10, calmodulin, EPHB2, HDAC4, and SEPP1 in CRC cells. Curcumin inhibits focal adhesion kinase (FAK) phosphorylation and enhances the expressions of several extracellular matrix components which play a critical role in invasion and metastasis. Curcumin reduces CD24 expression in a dose-dependent manner in CRC cells. Moreover, E-cadherin expression is upregulated by curcumin and serves as an inhibitor of EMT. These results suggest that curcumin executes its antimetastasis function through downregulation of Sp-1, FAK, and CD24 and by promoting E-cadherin expression in CRC cells.Keywords
Funding Information
- National Science Council (NSC98-2314-B-002-120-MY3, NSC98-2314-B-002-022-MY3, NSC102-2911-I-002-303, 102R7557)
- National Science Council (NSC98-2314-B-002-120-MY3, NSC98-2314-B-002-022-MY3, NSC102-2911-I-002-303, 102R7557)
- National Science Council (NSC98-2314-B-002-120-MY3, NSC98-2314-B-002-022-MY3, NSC102-2911-I-002-303, 102R7557)
- National Science Council (NSC98-2314-B-002-120-MY3, NSC98-2314-B-002-022-MY3, NSC102-2911-I-002-303, 102R7557)
This publication has 52 references indexed in Scilit:
- Curcumin Attenuates β-catenin Signaling in Prostate Cancer Cells through Activation of Protein Kinase D1PLOS ONE, 2012
- Increased burden of colorectal cancer in AsiaWorld Journal of Gastrointestinal Oncology, 2012
- Multitargeting by curcumin as revealed by molecular interaction studiesNatural Product Reports, 2011
- Curcumin Induces EGFR Degradation in Lung Adenocarcinoma and Modulates p38 Activation in Intestine: The Versatile Adjuvant for Gefitinib TherapyPLOS ONE, 2011
- Sp1 acetylation is associated with loss of DNA binding at promoters associated with cell cycle arrest and cell death in a colon cell lineMolecular Cancer, 2010
- Kisspeptin-10, a KISS1-Derived Decapeptide, Inhibits Tumor Angiogenesis by Suppressing Sp1-Mediated VEGF Expression and FAK/Rho GTPase ActivationCancer Research, 2009
- Curcumin inhibits cellular condensation and alters microfilament organization during chondrogenic differentiation of limb bud mesenchymal cellsExperimental & Molecular Medicine, 2009
- Curcumin Decreases Specificity Protein Expression in Bladder Cancer CellsCancer Research, 2008
- E-Cadherin Is Required for Caveolin-1-Mediated Down-Regulation of the Inhibitor of Apoptosis Protein Survivin via Reduced β-Catenin-Tcf/Lef-Dependent TranscriptionMolecular and Cellular Biology, 2007
- Regulation of E-cadherin and TGF-β3 expression by CD24 in cultured oral epithelial cellsBiochemical and Biophysical Research Communications, 2006